Replies to post #27049 on The Rising Influence of Rising Affluence

[semi_infinite]

Interesting micro fiber technology. There should be a good market if it works better than cadaver grafts. Reminds me of Vericel for cartilage (no overlap).

[DewDiligence]

ZBH reports 4Q22 results—issues 2023 guidance:

https://finance.yahoo.com/news/zimmer-biomet-announces-fourth-quarter-113000895.html

2023 non-GAAP EPS guidance is $6.95-7.15, which is 1-4% growth vs 2022 non-GAAP EPS of $6.89.